Literature DB >> 1238090

The effect of external deoxyribonucleosides on deoxyribonucleoside triphosphate concentrations in human lymphocytes.

M H Tattersall, K Ganeshaguru, A V Hoffbrand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1238090     DOI： 10.1016/0006-2952(75)90025-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  9 in total

1.  Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency.

Authors:  A Cohen; L J Gudas; A J Ammann; G E Staal; D W Martin
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

2.  Selective toxicity of purine deoxynucleosides for human lymphocyte growth and function.

Authors:  E W Gelfand; J J Lee; H M Dosch
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

3.  Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.

Authors:  B S Mitchell; E Mejias; P E Daddona; W N Kelley
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

Review 4.  The fluoropyrimidines: biochemical mechanisms and design of clinical trials.

Authors:  M A Friedman; W Sadée
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

5.  Low dose of deoxyguanosine increases IL-2 receptors of IL-2-dependent cultured T cells.

Authors:  T Noma; B Klein; J Yata; B Serrou
Journal:  Immunology       Date:  1984-06       Impact factor: 7.397

6.  Isotope-dilution analysis of the effects of deoxyguanosine and deoxyadenosine on the incorporation of thymidine and deoxycytidine by hydroxyurea-treated thymus cells.

Authors:  F W Scott; D R Forsdyke
Journal:  Biochem J       Date:  1980-09-15       Impact factor: 3.857

7.  Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools.

Authors:  A Meyerhans; J P Vartanian; C Hultgren; U Plikat; A Karlsson; L Wang; S Eriksson; S Wain-Hobson
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

8.  Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.

Authors:  A Cohen; R Hirschhorn; S D Horowitz; A Rubinstein; S H Polmar; R Hong; D W Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

9.  The effect of G2-treatments with 2'-deoxyadenosine on the frequency of chromatid aberrations in human lymphocytes depends on the type of culture.

Authors:  B A Kihlman; H C Andersson
Journal:  Chromosoma       Date:  1984       Impact factor: 4.316
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.